The Procter & Gamble (PG) CEO Paul Gama Sells $698K of Stock

On October 23, 2026, Paul Gama, the CEO of Health Care at The Procter & Gamble Company (PG), sold 4,331 shares at a price of $161.27 each, totaling approximately $698,460. This transaction was reported in a Form 4 filing with the SEC. Gama's sale reduced his holdings by 8.47%, leaving him with about 46,793 shares.

PG The Procter & Gamble Company

$161.02 ▲ +16.86% year to date

1M 3M YTD

Daily close · Oct 23, 2026

Inside Paul Gama's Trade

Gama's sale reflects a significant move, as he sold the shares for $161.27 on the same day the stock closed at $161.02. This suggests that he sold at a slight premium to the market price, which can indicate confidence in the stock's value. While insider sales can raise questions, they do not always signal negative sentiment.

Other Institutional Activity in Procter & Gamble

Several institutional investors adjusted their positions in Procter & Gamble around the same time. Capital Investment Advisors raised its stake by 17,061 shares, bringing its total to 462,434 shares worth about $67.2 million. Mutual of America Capital Management added 13,546 shares, increasing its holdings to 253,659 shares valued at approximately $36.9 million. Conversely, Wilmington Savings Fund Society reduced its position by 18,433 shares, now holding 315,785 shares worth about $45.9 million.

The Procter & Gamble Company Stock Down 2.1%

Procter & Gamble's shares recently traded around $161.02, which is about equal to its closing price on October 23, 2026. The stock is currently above its 50-day moving average by about 8.5% and its 200-day moving average by approximately 8.4%. However, it remains about 3.7% below its 52-week high of $167.25.

Recent Earnings

Procter & Gamble reported trailing twelve-month revenue of $87.9 billion, with earnings per share at $6.64. The company has shown a revenue growth of 4.0% year over year. The next earnings report is scheduled for January 21, 2027.

Dividend

Procter & Gamble pays an annual dividend of $4.35 per share, resulting in a yield of 2.7%. The company's dividend payout ratio is 64.6%, indicating a healthy return to shareholders.

Insider Buying and Selling at The Procter & Gamble Company

In addition to Paul Gama's recent sale, other insiders also sold shares on October 5, 2026. Susan Street Whaley, an officer, sold 2,369 shares, while Chief Financial Officer Andre Schulten sold 3,914 shares, all at a price of $145.34. These transactions occurred before Gama's sale and highlight ongoing insider activity at the company.

Analysts Set New Price Targets

On October 23, 2026, several analysts updated their ratings for Procter & Gamble. Freedom Broker upgraded the stock to a Buy rating with a target of $176.00. UBS maintained its Buy rating with a target of $190.00, while Citigroup also kept its Buy rating, raising its target to $187.00. BNP Paribas maintained an Outperform rating with a target of $189.00, and JP Morgan kept its Overweight rating with a target of $180.00. The mean price target among analysts is $172.35, suggesting a positive outlook.

About Procter & Gamble

The Procter & Gamble Company provides a wide range of consumer packaged goods globally. It operates in various segments, including Beauty, Grooming, Health Care, and Fabric & Home Care. This recent insider activity and analyst interest may reflect the company's strong market position and growth potential.

Bottom Line

Watch for Procter & Gamble's next earnings report on January 21, 2027, as it may provide further insights into the company's performance. Gama's recent sale and the adjustments by other institutional investors highlight ongoing changes in sentiment around the stock.